 | The new Access to Medicine Index
A letter to the editor from the Access to Medicine Foundation responding to earlier correspondence from Health Action International. |
 | Global initiatives to promote wider access to medicines
At least a third of the world’s population lacks essential, effective medicines, particularly for infectious diseases, such as HIV and malaria. Now, various initiatives have been launched or will soon become operational that promise to tackle obstacles involved in the chain from manufacture to local supply. |
 | The new Access to Medicine Index
The Access to Medicine Foundation’s new index set out to improve access to medicines through a transparent, quantifiable comparison of corporate social responsibility for 20 pharmaceutical companies. (Two letters in ‘Correspondence’) |
 | New ranking may be unpopular, but it’s here to stay
Pharmaceutical companies are not happy, but a number of influential investors have expressed their support for the Access to Medicine Index. |
 | Betere zorg voor twee miljard
Voor twee miljard mensen is betaalbare gezondheidszorg ontoegankelijk. Farmaceutische bedrijven kunnen veel betekenen om de gezondheidszorg
voor hen beter bereikbaar te maken, mits ze erkend worden in hun bijdrage..
|
 | 'Medicijnen moeten over de hele wereld beschikbaar zijn'
Deze zomer werd de Access to Medicine Index gepresenteerd, een meetlat voor de inzet van farmaceutische bedrijven om medicijnen wereldwijd betaalbaar te maken. |
 | Big pharma and good corporate citizenship
The impact of company policies on the availability of patented products in poor countries is largely unknown and it’s all but a total mystery as to how much of a company’s research budget is spent on discovering cures for diseases that affect the poor. Until now, that is… |
 | Access to Medicine in the Developing World
Audio (mp3) of a 5 minute interview by Jerome McDonnell, host of the Worldview program, with Wim Leereveld. |
 | Transparency is key to making HIV drugs accessible to those who need them
This month the global community will converge at the International AIDS Conference in Mexico City. Despite an enormous amount of worldwide attention, an estimated 33.2 million people in the world remain afflicted with AIDS. |
 | Bill Gates: Making Capitalism More Creative
In a piece on ‘Creative Capitalism’, Microsoft Chairman Bill Gates holds up the Access to Medicine Index as an example: “..This summer, a Dutch nonprofit called the Access to Medicine Foundation started publishing a report card that shows which pharmaceutical companies are doing the most to make sure that medicines are made for — and reach — people in developing countries.”.. Read full article online > |
 | Ranking sobre las políticas de los laboratorios para el sumnistro de fármacos a los países más pobres
Un ranking elaborado por la fundación holandesa Access to Medicine, ha señalado aquellos laboratorios que cuentan con mejores políticas de suministro de fármacos a los países más pobres, según informa el portal Atmindex.org. |
 | MSF says pharmaceutical companies not doing enough to fight AIDS and TB
..Last month, the Access to Medicine Foundation launched the Access to Medicines Index, a comprehensive listing of the pharmaceutical companies that have worked the most to increase access to medicines for all… |
 | GSK ranked No 1 on first ‘Access to Medicine’ Index
The first Access to Medicine (ATM) Index developed by the Access to Medicine Foundation, an independent international non-profit organization, has ranked GlaxoSmithKline (GSK) as the current industry leader when it comes to improving access to drugs and accines in low income countries, GSK’s local office said in a press release. |
 | Medicijnen voor Afrika
Ontwikkelingslanden moeten het vaak zonder medicijnen stellen. Een ranglijst van de inzet van farmaceuten om de bevolking te helpen, moet aansporen tot meer actie. |
 | Big Pharma hilft der Dritten Welt
Der fehlende Zugang zu verlässlichen und erschwinglichen Medikamenten und Impfstoffen kostet welweit jährlich zehn Millionen Menschen das Leben. Eind niederländischen Stiftung hat nun einen Index über das Engagement der 20 grössten Pharmakonzerne in Entwicklungsländern erstellt.
|
 | GSK leads the world in access to medicine rankings as generic companies trail
GlaxoSmithKline, Novo Nordisk and Merck & Co are the three major life science companies doing most to promote access to medicine in the developing world, a recently released study has found. more > |
 | Europäische Firmen sind engagierter
Pharmafirmen übernehmen einer Studie zufolge mehr soziale Verantwortung. Dabei schneiden insbesondere europäische Unternehmen im Vergleich gut ab. |
 | 'Not a true picture of access to crucial treatment'
A letter to the editor of the Financial Times from Tim Reed, Director, Health Action International Global, Amsterdam, The Netherlands. |
 | 'Medicines index is deeply flawed'
A letter to the editor of the Financial Times from Mr Robert L. Mallett, President of the Pfizer Foundation and senior vice-president, WW Alliance Development, Philanthropy & Corporate Responsibility, Pfizer Inc, New York, NY, USA. |
 | The Access to Medicine Index released - Ranking Pharmaceutical Companies
Starting from the Pretoria patent litigation in South Africa to the Novartis patent litigation in Chennai last year the big pharmaceutical companies in the world have endured a particularly brutal image bashing exercise…. more >
|
 | 'Gedragsindex over farmaceuten is zwak'
De nieuwe index over het gedrag van farmaceuten gaat te veel over de theorie en te weinig over de praktijk, zegt een consumentenorganisatie. |
 | Cipla, Ranbaxy at bottom in top 20 pharma firms’ survey
The domestic pharma majors, Cipla and Ranbaxy, have ranked at number 16 and 17 respectively among the 20 international pharma Companies that were evaluated by the Netherlands-based “Access to Medicine Index” for the year, 2008. |
 | A way to rank access to medicines
A letter to the editor of the Financial Times from Mr Jeremiah Norris, Director, Center for Science in Public Policy, Hudson Institute, Washington, DC. |
 | Rating Big Pharma
This week, the Access to Medicine Foundation, a charity based in the Netherlands, issued its first ranking of 20 pharmaceutical companies’ efforts to make key medicines available to the world’s poor.
|
 | A new ranking for pharmaceutical companies' efforts in the third world
An unusual ranking of pharmaceutical companies is being unveiled this week. |
 | Farmaceuten beoordeeld door pillen-index
Van alle twintig grote farmaceutische bedrijven zet de Engelse multinational GlaxoSmithKline zich het meest in om zijn medicijnen toegankelijk te maken voor ontwikkelingslanden. |
 | Nederlander neemt farmaceuten de maat
Een Nederlandse index peilt voor het eerst het maatschappelijk gedrag van farmaceutische bedrijven. „Ik moest snel mijn boeltje pakken.” |
 | Les pays pauvres, nouvel enjeu pour les laboratoires
Les laboratoires pharmaceutiques européens font plus d’efforts que les américains pour aider les pays pauvres à accéder aux médicaments. C’est ce qui ressort du classement publié, lundi 16 juin, par la fondation néerlandaise Access to medicine en collaboration avec l’organisme d’études spécialisé, Innovest. |
 | Index Ranks Pharmaceutical Groups According to Third World Outreach
An unusual ranking of pharmaceutical companies is being unveiled this week. It evaluates them by how easy they make it for patients in poor countries to get drugs and vaccines. |
 | Interview Wim Leereveld
Audio of the interview with Wim Leereveld about the launch of the Index. |
 | Europese farmabedrijven meest begaan met arme landen
Europese geneesmiddelenbedrijven doen meer om de toegang tot medicijnen in arme landen te verbeteren dan hun Amerikaanse concurrenten. Dat blijkt uit een rangschikking van farmafirma’s die de Nederlandse stichting Access to Medicine maakte, als leidraad voor investeerders die hun geld duurzaam willen beleggen. |
 | Glaxo heeft oog voor armen
Van de grote farmaciebedrijven doet het Britse GlaxoSmithKline het meest om medicijnen toegankelijker te maken voor arme landen. Europese farmaceuten doen meer aan dat probleem dan Amerikaanse. |
 | GSK leads pack in bringing drugs to the poor
European pharmaceutical companies – led by GlaxoSmithKline – outperform their US peers in efforts to make medicines available and affordable to the poor, according to an analysis to be released today.
|
 | 'Ze kunnen miljoenen levens redden'
Een Nederlandse index peilt voor het eerst het maatschappelijk gedrag van farmaceutische bedrijven. „Ik moest snel mijn boeltje pakken.” |
 | European firms beat U.S. on drug access for poor
European drug makers are better than their U.S. counterparts in ensuring medicines reach people in poor countries, with Britain’s GloxoSmithKline leading the field, according to an analysis on Monday. |
 | GSK tops new ethical ranking for investors
A new rating of 20 of the world’s biggest pharmaceutical companies by how ethically they treat the poor has given Britain’s GlaxoSmithKline top marks, followed by Denmark’s Novo Nordisk and Merck of the U.S. |
 | Top-20 gepubliceerd van farmaceutische multinationals
Audio (mp3) of a five-minute radio interview with Wim Leereveld, Chair of the Access to Medicine Foundation. |
 | GSK leads new index on access to medicine
GlaxoSmithKline (GSK) leads a new global index launched today that ranks pharmaceutical companies on their efforts to provide medicine to people at risk from poverty-related diseases such as malaria, tuberculosis and HIV/AIDS. |
 | Study: European firms outperform peers in drug-access efforts
European drugmakers have edged out other pharmaceutical firms in efforts to make treatments accessible and affordable to impoverished patients, according to an analysis by the Access to Medicines Index. |
 | GSK tops league on medicine access
European pharmaceutical companies – led by GlaxoSmithKline – outperform their US peers in efforts to make medicines available and affordable to the poor, according to an analysis. |
 | Interview Wim Leereveld
Audio of the interview with Wim Leereveld about the launch of the Index. |
 | Medikamente für Arme kommen aus Europa
Europas Pharma-Hersteller tun mehr für die Armen der Welt als ihre US-Konkurrenten. Das hat eine Studie ergeben, die am Montag veröffentlicht wird – trotz scharfen Widerstands in der Branche. |
 | 'We kunnen niet langer toekijken hoe de rest van de wereld crepeert’
Wim Leereveld legt farmaceutische bedrijven langs de meetlat: hoe goed doen zij hun best de minder bedeelden aan medicijnen te helpen? ‘Je moet de Acces to Medicine Index zien als een Michelinster voor de farmacie.’ |
 | New guide to help investors target ethical Pharma
HOW do you turn a growing desire among western investors to put their funds behind ethical companies into improved access to medication for poor people? The Access to Medicine Foundation, based in Haarlem, the Netherlands, has developed a set of criteria to assess how ethically pharmaceutical companies perform towards developing countries. |
 | Stimulerend lijstje
‘Eén tot twee miljard mensen in arme landen hebben geen toegang tot medicijnen. De Nederlander Wim Leereveld denkt een methode te hebben gevonden die grote farmaconcerns ertoe prikkelt die toegang te vergroten.’
© FEM Business
|
 | Het wespennest van de Farma-top-twintig
‘De eerste duurzaamheidsindex voor geneesmiddelenfabrikanten zal dit voorjaar een feit zijn. Initiatiefnemer Wim Leereveld wil alle partijen te vriend houden.’
|
 | L’industrie pharmaceutique face aux maladies du Sud
‘Les laboratoires pharmaceutiques se retrouvent aujourd’hui pris en tenaille….’
Jean Laville: ‘La création, en 2008, de l’Access to Medicine Index
incitera investisseurs et laboratoires à diffuser de bonnes pratiques’ |
 | Dutch initiative: Major investors sign up to Access to Medicine Index
‘Although it is only due to be launched in Spring 2008, ten major international investors have already declared their support for the Access to Medicine Index.’ |
 | Grote beleggers geven steun aan index voor toegang tot medicijnen
‘Een aantal grote beleggers heeft deze week officieel steun toegezegd aan de Access to Medicine Index die voorjaar 2008 verschijnt.’ |
 | Investors to rank big pharma on disease prevention
‘Index of pharmaceutical companies and their policies on acces to medicines will begin in spring next year.’ |
 | Access to Medicine, a new investor initiative
‘Eurosif member affiliates Ethos, F&C, Henderson, Schroders and SNS Asset Management have recently signed an Investor Statement acknowledging the Access to Medicine Index project..’ |
 | Access to Medicine: Ethos participates in a new investor initiative
‘Access to medicine is one of the main challenges of current development policies. Although it is primarily the responsibility of governments to facilitate access to medicine, pharmaceutical companies nevertheless bear a special responsibility.’ |
 | Ethos s'investit dans la cause de l'accès aux médicaments
‘Des médicaments pour tous! Emmenant avec elle ses investisseurs institutionnel et de nombreuses caisses de pension suisses, la fondation Ethos a annoncé hier sa participation….’ |
 | Index stimuleert bedrijven verantwoord te handelen ten opzichte van ontwikkelingslanden
‘Het wantrouwen jegens de farmaceutische industrie is groot. Er heersen veel misverstanden over deze sector. Dat komt vooral door een gebrek aan werkelijke kennis…’ |
 | Socially responsible investment
‘An index benchmarking the performance of pharmaceutical companies in providing access to their medicines is being developed by the investment research firm, Innovest Strategic Value Advisors, for institutional investors.’ |
 | Niemand wil als eerste buiten de boot vallen
‘De schellen vielen me van de ogen toen ik begreep dat de gemiddelde Afrikaan niet alleen nauwelijks aan de juiste pillen kan komen, maar ook met pijn móet leven…’ |
 | Breakthrough in Analyzing Access to Medicine Issues: Access to Medicine Index Introduced
“Innovest Strategic Value Advisors announced today the successful completion of the first phase of one of its most innovative current projects…” |
 | Pillenindex voor de armen
‘Een nieuwe index neemt farmareuzen de maat als het gaat om hun pillenbeleid voor arme landen.’
|
